Medical marketing spend is inching toward $30B, and DTC’s share is growing
January 15, 2019
By Neozene

It’s no surprise that medical marketing spending has skyrocketed in the past 20 years. And while marketing to physicians continues to consume the lion’s share of the almost $30 billion spent overall, direct-to-consumer marketing is catching up. Medical marketers spent $29.9 billion to get their messages in front of healthcare providers and consumers in 2016, up from $17.7 billion in 1997, according to a new survey assessing 20 years of industry marketing spending, published this week in the Journal of the American Medical Association. Of the 2016 total, $20.3 billion was spent

Read More

FDA Creating Innovation Office to Speed Drug Development
January 8, 2019
By Neozene

The FDA is creating an office of drug development science to cut the cost of bringing new medicines to patients, BioCentury reports. Staff at the office will create tools that sponsors and the FDA can use to streamline the development and regulatory assessment of drugs. FDA Commissioner Scott Gottlieb, M.D., is due to reveal the new office later Tuesday via videolink at the J.P. Morgan Healthcare Conference. In creating the office, Gottlieb thinks the FDA can leverage improved understanding of biomarkers and other advances to build tools that take some of

Read More

CRISPR Controls Obesity in Mice by Amplifying Rather Than Editing Genes
December 18, 2018
By Neozene

The genes SIM1 and MC4R regulate food intake by signaling the feeling of being full, which is why mutations in those genes are associated with severe obesity. Even if just one of the two copies of those genes that a person inherits from both parents is bad, he or she will most likely feel hungry all the time. What if the one working copy of a satiety-promoting gene could be turbocharged in some way to make up for the lack of functionality of the mutated copy? Scientists at the University

Read More